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1.1. Flavins and deazaflavins 
The role of vitamins in human health was first realized over a century ago. It was found 
that the deficiency of these essential small molecules, which were required in trace 
amounts, caused many diseases. The term vitamin, composed of the terms ‘vita’ (in Latin, 
vita = life) and ‘amine’, was coined in 1912 by Casimir Funk (Funk 1911). As it was later 
realized that vitamins are not always amines, the ‘e’ was omitted. Since then, almost one 
century long research on vitamins has significantly contributed towards our understanding 
of human health and disease. 
Like other vitamins, the role of riboflavin (vitamin B2) has been very well studied over the 
last few decades. Riboflavin consists of a tricyclic isoalloxazine ring with a ribityl tail at-
tached at position N10 (Figure 1A). The isoalloxazine moiety provides riboflavin an intense 
yellow color (in Latin, flavus = yellow). In fact, it is also used as colorant in food products. 
Riboflavin serves as a precursor of the flavin cofactors that are generated and used in cells 
for specific enzymes, the so-called flavoproteins. There are two ubiquitous riboflavin-
based flavin cofactors: (1) flavin mononucleotide (FMN), which is the 5’−OH phosphory-
lated product of riboflavin, and (2) flavin adenine dinucleotide (FAD), which is the result of 
the condensation of FMN with adenosine monophosphate (AMP). FAD and FMN generally 
form a non-dissociable (covalently as well as non-covalently attached) part of a flavopro-
tein hence serving as prosthetic groups. Flavin cofactors equip enzymes with redox func-
tionalities making them versatile biocatalysts. Flavoenzymes are found in many different 
enzyme classes, including e.g. dehydrogenases, oxidases, monooxygenases, reductases, 
and halogenases. Due to their catalytic versatility the range of processes in which flavopro-
teins play a crucial role is astounding and includes photoreception, light production, elec-
tron transfer pathways and degradation of xenobiotics. 
Except for the flavin cofactors mentioned above, there is another natural cofactor that 
shows quite some resemblance: cofactor F420 (Figure 1B). F420 is a so-called deazaflavin 
cofactor found in certain groups of microorganisms. It was first discovered and isolated in 
1972 by Cheesman et al from a methanogen (Cheesman et al. 1972) in which it plays a 
pivotal role in methane metabolism. For a long time, it was considered a very rare cofactor 
that only occurs in specific archaea. Later, it was also found to exist in various actinobac-
teria (Daniels et al. 1985) and recent genome sequence analyses have revealed that it also 
plays a role in other bacteria (Selengut and Haft 2010), such as cyanobacteria and some 
members of betaproteobacteria (Li et al. 2014; Ney et al. 2017). Its widespread occurrence 
in bacteria and archaea suggests that it fulfils important roles in these microbes. 
















Figure 1. Natural flavins (A) and 5-deazaflavins (B). FO stands for 7,8-didemethyl-8-hydroxy-5-
deazariboflavin. F4200 has an additional phospho-L-lactate group attached to FO. Cofactor F420 
carries a poly-γ-glutamate moiety (2-9 glutamates) attached to the lactyl group. 
1.2. Structure and properties of F420 
The redox-active moiety of cofactor F420 is the tricyclic ring which is structurally quite sim-
ilar to the regular flavins. Yet, when compared with the isoalloxazine part of riboflavin, F420 
has a carbon at position 5 instead of nitrogen and is regarded as a deazaflavin (Figure 1). 
This absence of the N5 attributes to its obligate two electron chemistry (hydride transfer) 
while, in contrast, riboflavin-based cofactors are also capable to support single electron 
transfers and oxygen reactivity. Besides that, there is a hydroxyl group at position 8 instead 
of methyl group and the no methyl group at position 7. The riboflavin analog of F420 is 7,8-
didemethyl-8-hydroxy-5-deazariboflavin and is called FO. Similar to riboflavin for the 
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biosynthesis of the FMN and FAD flavin cofactors, FO is the precursor for the full F420 co-
factor. The absorption spectrum of FO has a blue shift of about 50 nm when compared 
with the absorption spectrum of riboflavin which is typical for a 5-deazaflavin. The 8-hy-
droxy group of FO/F420 allows extensive (p-quinoid) conjugation as a result of relatively 
facile deprotonation of the phenolic moiety. This conjugation is interrupted in the reduced 
form of the deazaflavin cofactor (Figure 2). As a result of the differences in the isoalloxazine 
moiety, the redox potential of F420 (-360 mV) is much lower when compared with FAD or 
FMN (-240 mV). In fact, its redox properties are more similar to the nicotinamide cofactors 
by only catalyzing hydride transfer and displaying a low redox potential, which is even 





Figure 2. Protonation states of 5-deazaflavin (oxidized and reduced). 
Riboflavin is converted into a common flavin cofactor, FMN, by phosphorylation. In a next 
step, FMN is converted into FAD by the addition of an AMP moiety. The biosynthesis of F420 
is fundamentally different. While the deazariboflavin cofactor FO, shows still some similar-
ity with riboflavin, the first step in converting this precursor of F420 includes, except phos-
phorylation, also the incorporation of a lactyl moiety (vide infra). The next step in maturing 
the F420 cofactor involves the attachment of a poly-γ-glutamate tail, which is catalyzed in a 
step-wise manner. Clearly, there is a dedicated biosynthetic route towards F420 which is 
totally different from the route towards FMN/FAD and which involves unique enzymes to 
build this atypical redox cofactor. Only in the synthesis of the FO precursor some enzymes 
are shared with the riboflavin synthesis route. Intriguingly, the length of the poly-gluta-
mate moiety is organism dependent and is essential to prevent diffusion of the cofactor 
out of the cell while it does not play a role in catalysis. In most of the crystal structures, the 
16 | Introduction 
poly-glutamate chain has relatively little interactions with the protein and is often only 
partly bound to a patch on the surface of the respective deazaflavoprotein.  
 
Figure 3. Proposed biosynthetic pathway for F420. 
1.3. Biosynthesis of F420 
1.3.1. Biosynthesis of the deazariboflavin core, FO 
Analogous to riboflavin and its derivatives FMN and FAD, F420 is synthesized starting from 
a deazariboflavin precursor, the chromophore FO. FO already contains the catalytic moiety 
of the F420 cofactor and some F420 enzymes can even use this minimal deazaflavin as a co-
factor for catalysis (Hossain et al. 2015). FO also serves as light antenna molecule for DNA 
photolyases which repair thymine-thymine dimers. FO, in these enzyme complexes, trans-
fers energy to FAD (Glas et al. 2009). Intriguingly, the FO-containing DNA photolyases are 
from eukaryotic origin and therefore it is still unclear how these enzymes sequester FO as 
no deazaflavin biosynthetic genes have been reported for eukaryotes. 
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The biosynthetic pathway for riboflavin and the deazariboflavin FO diverges from a com-
mon intermediate; 5-amino-6-(ribitylamino)-2,4(1H,3H)-pyrimidinedione  (ribityldiamino-
uracil) (Figure 3) which is obtained from GTP after a multistep reaction. FO is synthesized 
by condensation of ribityldiaminouracil with tyrosine. A radical S-adenosyl-L-methionine 
(SAM) dependent enzyme, FO synthase, catalyzes this reaction. In archaea and cyanobac-
teria, FO synthase comprises two proteins encoded by two adjacent or non-adjacent genes 
(cofG and cofH in Methanocaldococcus jannaschii)(Graham et al. 2003). Both enzymes con-
tain one radical SAM site each and are capable of generating radicals independently. How-
ever, for FO production, the first reaction is catalyzed by CofH and it forms an intermediate 
product. This intermediate serves as substrate for CofG and eventually deazaflavin chro-
mophore formation takes place (Decamps et al. 2012). In bacteria, the same reaction is 
catalyzed by a bifunctional enzyme, FbiC, which is encoded by one fbiC gene. FbiC has N- 
and C-terminal domains each containing one radical SAM site (Choi et al. 2002; Graham et 
al. 2003). Detailed mechanistic studies has been carried out on these enzymes (Philmus et 
al. 2015). The fbiC gene, when cloned and expressed in E. coli cells, resulted in in vivo pro-
duction of FO (unpublished data). Since FO can diffuse across the cell membrane, FO pro-
duction was detected in the growth medium.  
1.3.2. Phospho-L-lactylization of FO 
Addition of the phospho-L-lactate group to the ribityl tail of FO leads to the formation of a 
polar molecule, F420-0. Unlike FO, F420-0 cannot easily diffuse across the cell membrane due 
to the charged group. The lactate group added to the FO has been argued to originate from 
lactaldehyde (Grochowski et al. 2006). An NAD+ dependent lactate dehydrogenase (CofA) 
catalyzes this reaction. As shown in figure 3, phosphorylation of lactate to 2'-phospho-l-
lactate is believed to be catalyzed by CofB. The reaction mechanism for this reaction is still 
not clear. The pyrophosphate linkage from GTP is used in this process. Two enzymes have 
been identified that catalyze the steps of forming an activated phospho-L-lactate interme-
diate, L-lactyl-2-diphospho-5'-guanosine (LPPG) (Grochowski et al. 2008) and to add this to 
the ribose moiety of FO (Figure 3). In Methanocaldococcus jannaschii, CofC and CofD are 
involved in such phosphorylation event. CofD (FbiA in actinobacteria) is a 2-phospho-l-lac-
tate transferase and structural data show that substrate dependent conformational 
changes initiate the condensation process. Upon action of CofD, the F420 precursor F420-0 is 
formed (Forouhar et al. 2008). It has not been reported whether this deazaflavin has any 
relevance as a cofactor. It is seen as precursor of the mature F420 cofactor. 
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1.3.3. Addition of poly-γ-glutamyl tail 
The last steps of maturation of the F420 cofactor entail the addition of an unusual poly-γ-
glutamyl tail. For this, dedicated enzymes, γ-glutamyl ligases, have been identified. The 
coupling of each L-glutamate moiety goes at the expense of a GTP molecule. For the ar-
chaeon M. jannaschii, CofE has been found to be responsible for this processive decoration 
of F420-0. In that case, as in other archaea, on average only 2 glutamates are coupled to 
form F420-2. In actinobacteria, the poly-γ-glutamyl tail is typically longer, in the range of 4 
to 9 glutamates long. The respective enzyme from Mycobacterium tuberculosis, FbiB, has 
been studied in detail recently. The longer peptide formed by FbiB, when compared with 
CofE, may be explained by an additional C-terminal domain in the bacterial enzyme. How-
ever, the exact mechanism of formation of the poly-γ-glutamyl tail is still unclear. Although 
a crystal structure of FbiB has been elucidated, even the details on how L-glutamates are 
incorporated in the growing peptide (by insertion or extension) remain to be established. 
1.4. Physiological role of F420 
Cofactor F420 has an important role in metabolism of many microorganisms. The first com-
prehensive studies on F420-dependent enzymes focused on methanogenic archaea and re-
vealed a role of the deazaflavin cofactor in multiple pivotal enzymes. In fact, methanogens 
contain such high amounts of F420 that they can be detected by its cofactor specific fluo-
rescence (Doddema and Vogels 1978). Since the discovery of the F420 cofactor in 1972, a 
relatively small number of F420-dependent enzymes have been reported, mainly from 
methanogenic archaea and Streptomyces species (Greening et al. 2016). In methanogens, 
CO2, H2 and acetate are mainly fixed into methane. In the process of the reduction of CO2 
to CH4, F420-dependent hydrogenases/dehydrogenases come into play. The required elec-
trons mainly come from H2 by action of F420-dependent hydrogenases (Muth et al. 1987; 
Michel I et al. 1995; Mills et al. 2013), and in some cases from formate dehydrogenases 
(Tzeng et al. 1975) and secondary alcohol dehydrogenases (Berk and Thauer 1997). 
Only recent genome sequence analyses revealed that the F420 cofactor is also produced by 
many bacteria (Selengut and Haft 2010). Except for conservation of the F420 biosynthesis 
genes, predicted proteomes of many bacteria appear rather rich in F420-dependent pro-
teins. For example, the proteome of Rhodococcus jostii RHA1 is predicted to include >100 
deazaflavoproteins, most of them with unknown function. The deazaflavin biosynthetic 
genes are well conserved in actinobacteria and it has been shown that these bacteria con-
tain relatively high levels of the cofactor. M. smegmatis is typically used for isolating F420 
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because its high content of the cofactor and ease of cultivation (Isabelle et al. 2002; Bashiri 
et al. 2010). The role of F420 in actinobacteria has been most intensely studied for the path-
ogen M. tuberculosis. It appears that F420 is essential to resist oxidative stress for which M. 
tuberculosis cells sustain a high level of glucose-6-phosphate (Hasan et al. 2010) which is 
used by a F420-dependent glucose-6-phosphate dehydrogenases to generate F420H2. Sev-
eral quinone reducing F420H2-dependent reductases appear essential for this. The same 
reductases were found to be essential for activating antitubercular prodrugs. Also a F420H2-
dependent biliverdin reductase, generating bilirubin, adds to the capacity of M. tuberculo-
sis to withstand stress conditions (Ahmed et al. 2016). Except for combating (oxidative) 
stress, the deazaflavin cofactor is also used by other enzymes in M. tuberculosis: for exam-
ple, for biosynthesis of a special kind of mycobacterial lipid, phthiocerol dimycocerosates, 
a F420H2-dependent phthiodiolone ketoreductase is produced, while a F420-dependent hy-
droxymycolic acid dehydrogenase is essential for the biosynthesis of ketomycolic acids 
(Purwantini and Mukhopadhyay 2013). The genome of M. tuberculosis is predicted to con-
tain more deazaflavoenzymes, awaiting identification and future biochemical studies to 
reveal their role in metabolism. 
1.5. Biocatalytically relevant F420-dependent enzymes  
F420-dependent enzymes represent a diverse group of unexplored biocatalysts which play 
an important role in archaeal and bacterial metabolism(Greening et al. 2016). In archaea, 
F420-dependent enzymes serve a function in central metabolic pathways. It is estimated, 
based on genome sequence analysis, that around 1 out of 10 bacteria contain the required 
genes for F420 biosynthesis (Selengut and Haft 2010). Based on homology searches using 
the sequences of known deazaflavoproteins, F420 producing bacteria are predicted to con-
tain many (uncharacterized) F420-dependent enzymes. Future studies will reveal the full 
biocatalytic potential of these redox enzymes. Being an obligate hydride transferring co-
factor, F420-dependent enzymes are expected to correspond to dehydrogenases and re-
ductases. Yet, it may also be that new activities will be revealed by studying novel F420-
dependent enzymes. For example, some F420-dependent enzymes may have evolved ways 
to utilize the unique photoreactive properties of the deazaflavin cofactor, similar to FO in 
DNA photolyases. 
Based on the current biochemical knowledge, it is clear that there are several distinct struc-
tural families that contain F420-dependent enzymes. Especially the elucidation of crystal 
structures of a number of these F420-dependent enzymes has helped to realize the distinct 
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features of various deazaflavoprotein classes. Concerning their catalytic properties, they 
can be divided into two types: 1) those which use oxidized form of the F420 (dehydrogen-
ases), and 2) those that use the reduced form of the cofactor (reductases). This is analo-
gous to the superfamily of nicotinamide cofactor dependent enzymes. Below, some F420-
dependent enzymes are highlighted in the context of their potential use as biocatalysts. In 
Table 1, an overview of some F420-dependent enzymes is provided. 
1.6. F420H2 regenerating enzymes 
Since F420 is not commercially available, it has to be purified from a suitable host. Previous 
work has shown that the levels of the deazaflavin cofactor varies considerably among F420 
producers. Due to the intracellular level of F420 and the ease by which the organism can be 
grown, F420 is mostly isolated from M. smegmatis. Still, the yield of the cofactor is very low, 
upto 1.4 µmol/L (Isabelle et al. 2002). Clearly, when considering F420-dependent enzymes 
for biocatalysis, efficient cofactor recycling systems will be essential. Alternatively, one 
could opt for whole cell conversion using a host that expresses the deazaflavin cofactor. 
However, this does not seem to be a real option because the most common hosts for re-
combinant protein expression (e.g. E. coli, yeast, filamentous fungi) do not harbor the F420 
biosynthetic pathway. Therefore, it is essential to have efficient F420 regenerating enzymes 
available, analogous to the developed systems for NAD(P)H dependent biocatalysts. Both 
in archaea as well as in prokaryotes, such enzymes are available with a similar physiological 
function. As F420-dependent enzymes show greatest potential in performing selective re-
ductions, it will be most valuable to develop a toolbox of enzymes for the regeneration of 
F420H2 at the expense of a sacrificial cosubstrate. For generating the reduced deazaflavin 
coenzyme, F420-dependent glucose-6-phosphate dehydrogenases (FGD) and F420-depend-
ent alcohol dehydrogenases (ADF) are promising candidates. Alternatively, one could also 
consider the so-called F420:NADPH oxidoreductase (FNO). Though this enzyme assists 
methanogens in transferring the surplus of electrons from reduced F420 to NADP+, gener-
ating NADPH, FNO can also be used in the reverse mode. More details on these F420H2 
regenerating enzymes are provided below. 
1.6.1. F420-dependent dehydrogenases 
F420-dependent D-glucose-6-phosphate dehydrogenases (FGD) catalyze the oxidation of 
the substrate to 6-phospho-D-glucono-1,5-lactone which is spontaneously hydrolyzed to  
6-phosphogluconate. FGDs from several actinomycetes have been characterized. In case 
of M. tuberculosis, the physiological role of FGD is to provide the reduced form of F420 for 
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F420H2 dependent reductases. Interestingly, M. tuberculosis has both a NADP+-dependent 
D-glucose-6-phosphate dehydrogenase as well as a F420-dependent glucose-6-phosphate 
dehydrogenase, both tapping from the same pole of glucose-6-phophate. It has been 
shown that cells that accumulate glucose-6-phosphate as response to oxidative stress. M. 
tuberculosis knockout mutants lacking FGD (Δfgd) were significantly more sensitive to oxi-
dative stress. A similar observation was made for the FO synthase knockout mutant (ΔfbiC). 
This shows that the FGD plays a crucial role in M. tuberculosis, to sustain a sufficient level 
of F420H2 in the cytosol, to serve the F420H2-dependent enzymes. Work in this thesis (Chap-
ter 4) investigates new subclass of F420-dependent glucose-6-phosphate dehydrogenases 
from Nocardiacae and Cryptosporangium sp. These enzymes, unlike previously described 
enzymes, also accept other sugar-6-phosphates as substrate.  
 
 
Figure 4. F420-dependent glucose-6-phosphate dehydrogenases as F420H2 cofactor recycling sys-
tem. 
A disadvantage of the F420-dependent glucose-6-phosphate dehydrogenase is the required 
cosubstrate, glucose-6-phophate. As this is a rather expensive compound, FGD can only be 
considered when synthesizing high value compounds. As an alternative, one may consider 
F420-dependent alcohol dehydrogenases which belong to the same structural family as the 
FGDs (TIM barrel containing luciferase family). So far only two ADFs have been reported in 
literature. These enzymes accept a range of small (and cheap) alcohols and therefore are 
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interesting candidates for use in biocatalysis. With the available crystal structure of one of 
these ADFs, it may also be possible to improve them for biocatalytic purposes through en-
zyme engineering. 
1.6.2. F420:NADPH oxidoreductase (FNO) 
Another interesting candidate enzyme for the generation of F420H2 is the F420:NADPH oxi-
doreductase (FNO). FNO is thought to connect the anabolic NADPH pathway to the cata-
bolic F420 pathway as it catalyzes the reversible reduction of NADP+ using F420H2. Its physi-
ological function within the cell is to shuttle the reducing equivalents between nicotina-
mide and deazaflavin molecules. In methanogens, this enzyme acts as a F420H2-dependent 
NADP+ reductase, whereas in prokaryotes, it seems to act as a NADPH-dependent F420 re-
ductase. In the latter catalytic mode, one can envisage its use for the generation of F420H2 
at the expense of NADPH. Many systems have been developed for generating NADPH using 
cheap starting compounds, such as glucose in combination of a NADP-dependent glucose 
dehydrogenase. Though such F420H2 regeneration system would rely on several enzymes, 
the well-developed nicotinamide recycling systems make this approach appealing when a 
robust FNO is available. In addition to that, FNO may serve as ‘bridge’ recycling enzyme in 











Figure 5. F420:NADPH oxidoreductase as F420H2 recycling system. Phosphite dehydrogenase 
(PTDH) can be used for NADPH recycling. 
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F420 Oxidoreductase Reaction catalyzed Reference 
Rossman fold   
F420:NADPH oxidoreductase (FNO)/ F420H2 dependent NADP+ 
reductase 
NADPH + F420  NADP+ + 
F420H2 
This thesis 
TIM barrel fold   
F420-dependent glucose-6-phosphate dehydrogenase (FGD) D-glucose-6-phosphate + F420 
D-6-phosphoglucono-1-lactone + F420H2 
(Nguyen et al. 
2016) 
F420-dependent sugar-6-phosphate dehydrogenase (FSD)  This thesis 
Alcohol dehydrogenase (ADF) Isopropanol + F420                             Acetone + 
F420H2 
(Aufhammer et al. 
2004) 
Methylene hydropterin reductase (Mer)    
F420 dependent hydroxymycolic acid dehydrogenase Hydroxy-mycolic acid + F420  




Split β-barrel like fold   
Deazaflavin dependent nitroreductase (Ddn) PA824 (Prodrug) + F420H2                           PA824 
(Active) + F420  
(Cellitti et al. 2012) 
Biliverdin reductase Biliverdin + F420H2                                 Bilirubin + F420 (Ahmed et al. 2016) 
Aflatoxin degrading FDRs Reduction of α,β unsaturated bonds (Gurumurthy et al. 
2013) 
                F420 dependent oxidoredutases (FDORs)   
F420 dependent ene-reductase Reduction of α,β unsaturated bonds This thesis 
Table 1. Some F420-dependent enzymes. 
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1.7. F420-dependent reductases 
Due to the relatively low redox potential, F420-dependent enzymes are predicted to be ef-
fective in reductions. In line with this, many of the described deazaflavoenzymes function 
as reductases. The generation of the required reduced form of the deazaflavin coenzyme 
is accomplished by the enzymes mentioned above. Intriguingly, the F420-dependent reduc-
tases described in literature have hardly been explored for biocatalytic purposes. Most of 
the known examples have been studied in the context of elucidating a metabolic pathway 
or understanding the mode of action of prodrugs. The latter mainly refers to the finding 
that is M. tuberculosis a deazaflavin-dependent nitroreductase (Ddn) (Cellitti et al. 2012) 
has been shown to be responsible for the activation of the prodrug PA-824 (Pretonamid) 
into an active toxic form (Manjunatha et al. 2006; 2008). This promising prodrug PA-824 
and similar nitroimidazoles are currently in clinical trials. The activated form of PA-824 
leads to the release NO after reduction by Ddn. This NO, in turn, kills M. tuberculosis, in-
cluding the non-replicating form of the organism (Singh et al. 2008). This is important be-
cause other drugs can only target the active form of M. tuberculosis and TB, most of the 
cases is dormant for years. 
Apart from M. tuberculosis, other members of actinobacteria such as R. jostii RHA1, M. 
smegmatis, and T. fusca also have a large number of F420-dependent enzymes most of 
which are yet to be characterized. F420-dependent reductases are part of the split β-barrel 
enzyme superfamily (FDORs) (Ahmed et al. 2015). These enzymes are distantly related to 
FMN-dependent pyridoxamine 5'-phosphate oxidases (PNPOx).  
Some members of F420-dependent reductases (FDR) catalyze the reduction of α,β-unsatu-
rated esters of recalcitrant aflatoxin compounds (Taylor et al. 2010). Some enzyme from 
M. tuberculosis help in persistence by reducing quinones, xenobiotics and bactericidal 
agents (Gurumurthy et al. 2013; Jirapanjawat et al. 2016). Reductases from M. smegmatis 
has been also shown to reduce diverse compounds through common mechanism 
(Greening et al. 2017). However, these enzymes have not been explored as biocatalysts for 
enantio- and/or regioselective reductions. Our work on F420-dependent reductases (chap-
ter 5) shows that these enzymes display a broad substrate scope and can catalyze ene-
reduction reactions in an enantio- and regioselective manner. Crystal structures of several 
of these small F420-dependent reductases have been solved which will accelerate the im-
provement of these enzymes as efficient biocatalysts through enzyme engineering. 
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1.8. Aim and outline of the thesis 
The main goal of the work described in this thesis was to identify, characterize and engi-
neer bacterial F420-dependent enzymes for their potential use as biocatalysts. Both ge-
nome mining and proteomic techniques were explored in order to identify such deazafla-
voenzymes. Since there are relatively few deazaflavoenzymes characterized till date, we 
did not restrict ourselves to one particular class of enzyme. Several novel F420-dependent 
enzymes have been discovered and studied in detail (chapters 2-5, see below). Except for 
deazaflavoenzymes, also work has been performed on identifying flavin-containing 
monooxygenases that can convert furanoid compounds (chapter 6). 
Chapter 2 involves a proteomic approach aimed at identifying F420-binding proteins. By 
generating F420-bound column material, an affinity chromatography method was devel-
oped and validated. By using recombinantly expressed F420-dependent glucose-6-phos-
phate dehydrogenase it could be shown that this method indeed is able to isolate F420-
binding proteins. The method was used to identify the novel F420-binding proteins by ana-
lyzing cell free extract of M. smegmatis cells. Upon SDS-PAGE and MS analyses, several 
putative F420-binding proteins were identified. While, based on their protein sequence, a 
large portion of the isolated proteins are predicted to be F420- dependent, some of the 
identified proteins have not been studied before. Future studies will reveal for what pur-
pose these proteins utilize the deazaflavin cofactor. 
In chapter 3, a newly identified F420:NADPH oxidoreductase (Tfu-FNO) from the mesother-
mophile Thermobifida fusca is described. Except for establishing an expression and purifi-
cation protocol for this deazaflavoenzyme, also a detailed characterization was performed. 
This resulted in elucidation of its crystal structure, in complex with NADP+. Tfu-FNO is a 
valuable biocatalyst for regenerating reduced F420 at the expense of NADPH, or vice versa. 
Since wild-type Tfu-FNO is specific for NADP+/NADPH and has very poor activity towards 
NAD+/NADH, mutant enzymes were prepared in order change the nicotinamide coenzyme 
specificity. 
Chapter 4 describes a thorough sequence analysis of the family of sequence-related F420H2-
dependent alcohol dehydrogenases. This revealed that this specific family of deazaflavoen-
zymes has evolved from an FMN-dependent ancestral enzyme. A predicted ancestral se-
quence of a F420-dependent alcohol dehydrogenases was used to resurrect the correspond-
ing protein. By using a synthetic gene, this ancestral protein was expressed and purified. 
Biochemical characterization revealed that it acts as a glucose-6-phosphate dehydrogen-
ase and that it exhibits a relatively high thermostability. As part of this study, also a new 
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subgroup of dehydrogenases was identified. Expression and characterization of a repre-
sentative revealed that it has a somewhat more relaxed substrate acceptance profile when 
compared with the closely related F420-dependent glucose-6-phosphate dehydrogenases. 
These data provide new insights in how F420-dependent dehydrogenases have evolved over 
time. 
The work described in chapter 5 concerns an explorative study of F420H2-dependent reduc-
tases. While such reductases had been described in literature as enzyme capable to reduce 
quinoid substrates, here it was shown for the first time that they can be exploited as bio-
catalysts for regio- and enantioselective reductions of α,β-unsaturated ketones and alde-
hydes. The observation that the enantioselectivity is opposite to the flavin-dependent re-
ductases that are typically used for such reactions, confirm that the F420H2-dependent re-
ductases are structurally and mechanistically different from the most widely applied re-
ductases. The observed excellent enantioselectivities indicate that this is an interesting 
group of reductases in the context of biocatalysis. Future enzyme engineering efforts 
aimed at improving the rate of catalysis may turn them into potent biocatalysts. 
In chapter 6, FAD-containing Baeyer-Villiger monoxygenases (BVMO) were tested for their 
ability to convert furanoid aldehydes. Interestingly, most of the tested BVMOs were found 
to be active on these compounds. Product analysis revealed that the acid form (instead of 
formate ester) was formed as product using furfural and furfural derivatives (HMF, DFF 
and FFA) as substrates. A mutant of phenylacetone monooxygenase (PAMO) showed a rel-
atively high activity towards furanoid aldehydes. This study shows that BVMO are interest-
ing biocatalysts for the conversion of furanoid compounds and could perhaps serve a role 
in the recent interest in producing 2,5-furandicarboxylic acid (FDCA) starting from 5-(hy-
droxylmethyl)furfural (HMF) Although at slower rate, these enzymes could oxidize both 
the aldehyde groups of DFF to a bioplastic precursor, FDCA. 
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